Abiopharma

🔍 Flammer Martina M.D. (Executive)

Company: INSMED Inc (INSM)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 13,680 shares of Common Stock at $34.03 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 96,791.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 17,160 shares of Common Stock at $26.46 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 113,951.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25,710 shares of Common Stock at $26.43 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 139,661.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 38,846 shares of Common Stock at $17.07 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 178,507.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 13,072 shares of Common Stock at $19.74 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 191,579.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 36,555 shares of Common Stock at $18.95 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 228,134.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 23,835 shares of Common Stock at $29.13 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 251,969.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 17,790 shares of Common Stock at $25.83 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 269,759.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 19,066 shares of Common Stock at $141.27 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 250,693.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,877 shares of Common Stock at $142.03 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 244,816.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 35,245 shares of Common Stock at $143.16 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 209,571.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 28,063 shares of Common Stock at $144.05 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 181,508.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 63,782 shares of Common Stock at $145.33 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,726.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 34,615 shares of Common Stock at $146.05 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 83,111.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 13,680 shares of Stock Option (right to buy) at $34.03 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2031-01-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 17,160 shares of Stock Option (right to buy) at $26.46 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2031-05-12 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 25,710 shares of Stock Option (right to buy) at $26.43 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | shares_owned_after: 8,570.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 38,846 shares of Stock Option (right to buy) at $17.07 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2032-05-11 | equity_swap_involved: 0 | shares_owned_after: 25,898.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 13,072 shares of Stock Option (right to buy) at $19.74 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2033-01-05 | equity_swap_involved: 0 | shares_owned_after: 13,073.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 36,555 shares of Stock Option (right to buy) at $18.95 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2033-05-11 | equity_swap_involved: 0 | shares_owned_after: 73,110.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 23,835 shares of Stock Option (right to buy) at $29.13 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2034-01-04 | equity_swap_involved: 0 | shares_owned_after: 39,725.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 17,790 shares of Stock Option (right to buy) at $25.83 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2034-05-13 | equity_swap_involved: 0 | shares_owned_after: 53,370.00 | transaction_form_type: 4 | Footnotes: F1, F10

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
• F2: This is the weighted average sales price representing 19,066 shares sold at prices ranging from $140.56 to $141.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F3: This is the weighted average sales price representing 5,877 shares sold at prices ranging from $141.61 to $142.55 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F4: This is the weighted average sales price representing 35,245 shares sold at prices ranging from $142.70 to $143.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F5: This is the weighted average sales price representing 28,063 shares sold at prices ranging from $143.70 to $144.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F6: This is the weighted average sales price representing 63,782 shares sold at prices ranging from $144.70 to $145.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F7: This is the weighted average sales price representing 34,615 shares sold at prices ranging from $145.70 to $146.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F8: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
• F9: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
• F10: The options become exercisable based on the following vesting schedule: 25% vest on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the Initial Vesting Date.
• REMARKS: Exhibit List - Exhibit 24 - Power of Attorney